EIF2AK3 and Parkinson disease: Early studies on post-mortem brain samples identified the presence of p-PERK and p-eIF2α in the substantia nigra of PD brain in which 5–20% of the α-synuclein positive neurons were immunoreactive for p-PERK while it was absent in the control non-PD brain [158].